Correction: Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model

Correction: Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model

Saved in:

Bibliographic Details
Main Authors:	Wanqiong Chen, Limian Hong, Shaomei Lin, Na Xian, Cailing Yan, Ningning Zhao, Yonglei Xiao, Wanting Liao, Yuxiang Huang, Mingzhu Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Oncology
Subjects:	CAR-T cells glioblastoma IL-15 CCL19 cancer immunotherapy EGFR vIII
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1645247/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model
by: Wanqiong Chen, et al.
Published: (2025-03-01)

Integrating experimental and network pharmacology to explore the pharmacological mechanisms of Dioscin against glioblastoma
by: Huang Jianhui, et al.
Published: (2025-05-01)

Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide
by: Paolo Tini, et al.
Published: (2025-07-01)

High p16INK4A expression in glioblastoma is associated with senescence phenotype and better prognosis
by: Soon Sang Park, et al.
Published: (2025-02-01)

Myeloid‐Derived Suppressor Cell Accumulation Drives Intestinal Fibrosis through mCCL6/hCCL15 Chemokine‐Mediated Fibroblast Activation
by: Xiaohui Cheng, et al.
Published: (2025-02-01)

Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic pain
by: Mahtab Eivazitork, et al.
Published: (2025-07-01)

APOE Drives Glioma Progression by Modulating CCL5/CCR5 Signaling in the Tumor Microenvironment and Inducing M2 Macrophage Polarization
by: Wei Huang, et al.
Published: (2025-05-01)

Structural alterations of the EGFR gene in glioblastoma samples as a prognostic factor and molecular target for therapy
by: V. O. Varachev, et al.
Published: (2024-10-01)

Repurposing Osimertinib and Gedatolisib for Glioblastoma Treatment: Evidence of Synergistic Effects in an In Vitro Phenotypic Study
by: Vitória Santório de São José, et al.
Published: (2024-12-01)

Human cytomegalovirus UL23 inhibits immune cell migration and blocks antiviral immune cell responses by reducing the expression of chemokines CCL2 and CCL5
by: Hankun Wang, et al.
Published: (2025-12-01)

CCL3 correlates with ferroptosis in intervertebral disc degeneration and its prognostic significance
by: He Chen, et al.
Published: (2025-04-01)

Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastoma
by: Benjamin Lin, et al.
Published: (2025-06-01)

Study on expression levels of chemokine CCL5 in peripheral blood of patients with alopecia areata
by: TAN Yudan, et al.
Published: (2025-07-01)

Intranasal Immunization with DNA Vaccine HA-CCL19/Polyethylenimine/Chitosan Composite Provides Immune Protection Against H7N9 Infection
by: Yuqing Xiang, et al.
Published: (2024-12-01)

Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China
by: Duanchong Zhao, et al.
Published: (2024-12-01)

Klotho‐mediated targeting of CCL2 suppresses the induction of colorectal cancer progression by stromal cell senescent microenvironments
by: Yangyang Liu, et al.
Published: (2019-11-01)

Assessment of Nanosilymarin's Therapeutic Efficacy in Mitigating CCl4-Induced Hepatotoxicity in Rats
by: Nisreen Jasim
Published: (2025-06-01)

Silymarin effect as an antioxidant to improve damages induced by CCl4 on some characteristics of male rats reproductive system
by: Measer A. Ahmed, et al.
Published: (2023-01-01)

Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2024-12-01)

Clinical Significance of Combined Detection of CCL22 and IL‐1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma
by: Lei Cui, et al.
Published: (2024-11-01)

Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy
by: Hao Cui, et al.
Published: (2025-04-01)

Microvascular heterogeneity exploration in core and invasive zones of orthotopic rat glioblastoma via ultrasound localization microscopy
by: Xing Hu, et al.
Published: (2025-03-01)

Homologous tumor cell exosome-based drug delivery system co-delivering temozolomide and resveratrol for orthotopic glioblastoma therapy
by: Xuemei Wang, et al.
Published: (2025-12-01)

Prolactin promotes transepithelial migration of lymphocytes through CCL2
by: Peng Liu, et al.
Published: (2025-08-01)

Filamentous chemokine CCL5 structure and the functional aspects
by: Yi-Ting Yuan, et al.
Published: (2025-04-01)

Sonoporation with Echogenic Liposomes: The Evaluation of Glioblastoma Applicability Using In Vivo Xenograft Models
by: Ju-Hyun Park, et al.
Published: (2025-04-01)

The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma
by: A. V. Kaminskiy, et al.
Published: (2023-06-01)

A SORT1/EGFR molecular interplay as a prognostic biomarker in glioblastoma vasculogenic mimicry: implications in the transcriptional regulation of cancer stemness and drug resistance
by: Marie-Eve Roy, et al.
Published: (2025-08-01)

Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study
by: Syna Miri, et al.
Published: (2024-11-01)

VPS4B orchestrates response to nuclear envelope stress by regulating ESCRT-III dynamics in glioblastoma
by: Zuqian Wu, et al.
Published: (2024-12-01)

Integrin β8 Facilitates Macrophage Infiltration and Polarization by Regulating CCL5 to Promote LUAD Progression
by: Lei Song, et al.
Published: (2025-01-01)

Double and Triple Photoionization of CCl<sub>4</sub>
by: Antônio Carlos Fontes dos Santos, et al.
Published: (2024-12-01)

Association between RANTES/CCL5 levels with Plasmodium infections and malaria severity: a systematic review
by: Pattamaporn Kwankaew, et al.
Published: (2024-11-01)

Potential utility of urinary chemokine CCL2 to creatinine ratio in prognosis of 5‐year graft failure and mortality post 1‐year protocol biopsy in kidney transplant recipients
by: Michal Gniewkiewicz, et al.
Published: (2023-06-01)

CCL26 as a prognostic biomarker in hepatocellular carcinoma: integrating bioinformatics analysis, clinical validation, and radiomics score
by: Junjun Yan, et al.
Published: (2025-04-01)

ETCHING MECHANISM OF CCl<sub>4</sub>-DOPED GaAs GROWN BY MOCVD
by: Т. А. Bagaev, et al.
Published: (2013-08-01)

CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody–associated vasculitis
by: Weiwei Hao, et al.
Published: (2025-04-01)

Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
by: Anna Qin, et al.
Published: (2025-04-01)

Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis
by: Jinlei Mao, et al.
Published: (2024-03-01)

Auger electron-emitting EGFR-targeted and non-targeted [197Hg]Hg-gold nanoparticles for treatment of glioblastoma multiforme (GBM)
by: Madeline K. Brown, et al.
Published: (2025-07-01)